|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
2020 Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... sustained release, edivoxetine hydrochloride, ECH-201, ... centanafadine SR), PD-3044, CX717, brilaroxazine, SHX-009, SKL13865, dasotraline, SPN-810 (molindone hydrochloride ... ), SPN-812 (viloxazine hydrochloride), TAH9922 (atomoxetine hydrochloride ... Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, 2019 ... : Methylphenidate amphetamine dexmethylphenidate atomoxetine hydrochloride Centanafadine Eltoprazine Fasoracetam Dexamfetamine transdermal ... Molindone hydrochloride Report covers >20 drugs Drug ... Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Attention Deficit ... |